spacer
home > pmps > winter 2003 > the future of manufacturing - is outsourcing the solution?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Future of Manufacturing - Is Outsourcing the Solution?

Do you think that outsourcing of manufacturing is increasing or has it reached saturation?

The current growth rate is around seven per cent and I am sure this will continue into the future. The number of pharmaceutical manufacturing plants in Europe is still too large to be sustainable; closures or divestments will continue to occur. However, I believe the marketplace is changing. The largest volume growth is with the generic companies and they have no reason to invest in facilities to the same degree as the pharmaceutical companies in the 1950s and 1960s. I believe that they will continue to selectively outsource and we are seeing evidence of this already.

An additional further growth area for outsourcing will come from new products flowing through the pipeline from biotech companies. This group has been the most prolific in new product innovation and they have directed their resources into research, with many of the small biotech companies not having the resources to build and operate manufacturing facilities. They have grown up with product outsourcing as a way of life. I do not mean large companies like Lonza, Boehringer Ingelheim or DSM, which have the resources, but the small biotech companies. Most of the products require sophisticated facilities to produce active materials but the formulation delivery system can be tablets or capsules, which can be easily outsourced.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
An interview with Maurice Wolridge, CEO of FAMAR, a leading outsourcing company in Europe, by Patricia Lobo, Editor of PMPS and Senior Consultant at Technomark Consulting Services

Maurice Wolridge is Chief Executive of Famar ABE and was formerly Vice President Manufacturing for Pfizer before becoming a partner in Global Healthcare Partners, an executive group advising Credit Suisse First Boston Merchant Bank on health care acquisitions. More recently he was Chief Executive Officer of NextPharma Technologies, a portfolio company of Donaldson Lufkin Jenrette Merchant Banking Fund II. Maurice is non-executive Chairman of Alimentary Health, a biotechnology company exploring the health care characteristics of probiotic organisms. He has also been a Director of the US-Ireland Council for 10 years; an executive group dedicated to strengthening the economic social and cultural relationship between the two countries.

spacer
Maurice Wolridge
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement